The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer
- PMID: 7576746
- DOI: 10.3109/02841869509127187
The role of cul-de-sac aspiration cytology in the follow-up of ovarian cancer
Abstract
The methods most often used for follow-up of ovarian cancer are physical examination, CA-125 measurement and ultrasonography or computed tomography. In the present study the role of cul-de-sac aspiration cytology as a supplementary method was evaluated. We analyzed the records of 110 stage I-IV ovarian cancer patients who had undergone cul-de-sac aspiration as a part of their follow-up schedule after the primary treatment. During the median follow-up of 5 years altogether 577 cul-de-sac aspirations were performed with a median interval of 9 months. Only in 2 cases the obtained sample was insufficient for evaluation. Twenty patients had cul-de-sac cytology > or = class III at some point during the follow-up. In 12 cases the preceding or subsequent CA-125 values taken within 3 months were < 35 U/l. In 7 cases CA-125 values increased later, but in 5 cases the tumour marker values remained within normal range during the entire follow-up. Nine out of these 12 patients had a clinical recurrence later on, but 3 patients had no evidence of the disease. Twenty-seven recurrences were detected during the follow-up. Cul-de-sac aspiration cytology was the first or the only indication of recurrence in 9 cases (33%) and is a useful supplementary method in the follow-up of ovarian cancer.
Similar articles
-
Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma.Anticancer Res. 2007 Mar-Apr;27(2):1015-8. Anticancer Res. 2007. PMID: 17465236
-
Role of cul-de-sac aspiration cytology in the management and follow-up of patients with ovarian carcinoma. A preliminary report.J Reprod Med. 1985 Nov;30(11):867-70. J Reprod Med. 1985. PMID: 4078821
-
Pervaginal cul-de-sac cytology and CT in the follow-up care of patients with advanced ovarian cancer.Gynecol Oncol. 1986 Sep;25(1):84-8. doi: 10.1016/0090-8258(86)90068-5. Gynecol Oncol. 1986. PMID: 3732922
-
Ovarian cancer.Radiol Clin North Am. 2007 Jan;45(1):149-66. doi: 10.1016/j.rcl.2006.10.012. Radiol Clin North Am. 2007. PMID: 17157627 Review.
-
Imaging techniques for the evaluation of ovarian cancer.Best Pract Res Clin Obstet Gynaecol. 2014 Jul;28(5):697-720. doi: 10.1016/j.bpobgyn.2014.04.006. Epub 2014 Apr 30. Best Pract Res Clin Obstet Gynaecol. 2014. PMID: 24846098 Review.
Cited by
-
Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006119. doi: 10.1002/14651858.CD006119.pub2. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Sep 08;(9):CD006119. doi: 10.1002/14651858.CD006119.pub3. PMID: 21678351 Free PMC article. Updated.
-
Evaluation of follow-up strategies for women with epithelial ovarian cancer following completion of primary treatment.Cochrane Database Syst Rev. 2023 Aug 31;8(8):CD006119. doi: 10.1002/14651858.CD006119.pub4. Cochrane Database Syst Rev. 2023. PMID: 37650760 Free PMC article.
-
Evaluation of follow-up strategies for patients with epithelial ovarian cancer following completion of primary treatment.Cochrane Database Syst Rev. 2014 Sep 8;2014(9):CD006119. doi: 10.1002/14651858.CD006119.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2023 Aug 31;8:CD006119. doi: 10.1002/14651858.CD006119.pub4. PMID: 25198378 Free PMC article. Updated.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous